Abstract

Background: Breast and ovarian cancer are most common female cancer in Algeria in terms of incidence and mortality. Cancer cells are exposed to higher reactive oxygen species (ROS) whose levels support death evasion, angiogenesis, and metastasis. Less interest has been given to changes ROS homeostasis in cancer therapy. In this study, we investigate redox homeostasis before and after treatment (BT, AT), to determine detrimental or beneficial outcomes in cancer therapy. Methods: Cancer patients were recruited at the Hospital of Maghnia with the engaging of healthy controls. Serum biochemical parameters and oxidant/antioxidant markers were determined. Results:Our findings showed oxidative stress (OS) reflected by an increase in malondialdehyde (MDA), carbonyl proteins (CP), superoxide anion (O2Ÿ-), nitric oxide (NOŸ) and peroxynitrite (ONOO-) levels and a decrease in vitamins C and glutathione (GSH), catalase, and superoxide dismutase (SOD) activities in cancer patients BT. After treatment (AT), levels of MDA, CP, O2Ÿ-, NOŸ , ONOO- were maintained high and/or increase vis-à-vis patients BT. The lowered activities of SOD, catalase and GHS level BT, heightened in cancer cases AT. Cholesterol, triglycerides and uric acid levels were increased in BC. Uric acid levels were markedly reduced in OC patients. HDL-cholesterol levels were significantly reduced in both cancer patients. Conclusion: Metabolic perturbations occurred with oxidative stress which highlights an adaptive appearance vis-à-vis of treatments. As a double-edged sword, redox-signalling markers may represent a crucial point and could be the future targets for anticancer drug research.  

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.